Davyd Chung, Ph.D.

Dr. Chung is a seasoned senior health executive with over 20 years of experience in business development, strategic growth and partnerships, market expansion, client relations, and Federal Health, leveraging his unique and diverse leadership success in the federal government, academia, and industry. He leads Digital Infuzion’s Growth function including market research and analysis, strategic planning, opportunity pipeline, and proposal development.

Prior to joining Digital Infuzion, Dr. Chung served as Vice President, Strategy and Growth, at DLH Corp., where he was responsible for leading business development across the Federal Health market including Health and Human Services (HHS) and Defense Health Agency (DHA). He helped oversee the business development and capture team and managed $2B+ pipeline, capture, and proposal processes.

Additionally, Dr. Chung held various past roles at NIH including Program Director for the Center to Reduce Cancer Health Disparities at the National Cancer Institute (NCI) and Program Officer for National Institute of Child Health and Human Development’s (NICHD) National Children’s Study.

Dr. Chung received his doctorate in Physiological Molecular Biology and Bachelor of Science in Biology from the University of Illinois at Urbana-Champaign.